University of Wisconsin Carbone Cancer Center

NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer

Retrieved on: 
Monday, October 30, 2023
Patient, Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, Gold, Policy, Weather, NCI, Publishing, Visit, Health, Fatigue, Cancer-related fatigue, Vomiting, Doctor of Philosophy, Palliative care, Nausea, Quality of life, University of Wisconsin Carbone Cancer Center, Caregiver, Disease, Medicine, National Cancer Institute, NCCN, University, Anschutz Medical Campus, Anemia, Diagnosis, Book, MS, Pharmaceutical industry, Nursing, Medical device, Residential care, Medical imaging, MD, Cancer

PLYMOUTH MEETING, Pa., Oct. 30, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual needs and priorities. Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care, part of an ongoing expansion of supportive care resources. The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care.

Key Points: 
  • Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care , part of an ongoing expansion of supportive care resources.
  • The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care .
  • All guides are available free-of-charge at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App .
  • Dr. Campbell stressed that palliative care is an important part of comprehensive cancer care regardless of age, cancer stage, or the need for other therapies.

NCCN Expands Focus on Quality of Life and Supportive Care with New Guides for People with Cancer

Retrieved on: 
Monday, October 30, 2023
Patient, Journal of the National Comprehensive Cancer Network, National Comprehensive Cancer Network, Gold, Policy, Weather, NCI, Publishing, Visit, Health, Fatigue, Cancer-related fatigue, Vomiting, Doctor of Philosophy, Palliative care, Nausea, Quality of life, University of Wisconsin Carbone Cancer Center, Caregiver, Disease, Medicine, National Cancer Institute, NCCN, University, Anschutz Medical Campus, Anemia, Diagnosis, Book, MS, Pharmaceutical industry, Nursing, Medical device, Residential care, Medical imaging, MD, Cancer

PLYMOUTH MEETING, Pa., Oct. 30, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) is announcing new resources focused on improving quality of life for people with cancer while making sure care planning reflects individual needs and priorities. Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care, part of an ongoing expansion of supportive care resources. The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care.

Key Points: 
  • Today marks the publication of a new NCCN Guidelines for Patients®: Palliative Care , part of an ongoing expansion of supportive care resources.
  • The new NCCN Guidelines for Patients: Fatigue and Cancer is also publishing, along with an updated book on managing Distress During Cancer Care .
  • All guides are available free-of-charge at NCCN.org/patientguidelines or via the NCCN Patient Guides for Cancer App .
  • Dr. Campbell stressed that palliative care is an important part of comprehensive cancer care regardless of age, cancer stage, or the need for other therapies.

IntraOp Medical Corporation Announces Their 10th Mobetron with FLASH-IQ Installation Worldwide

Retrieved on: 
Thursday, May 11, 2023
Radiology, Biotechnology, Oncology, General Health, Health, Medical Devices, Hospitals, Health Technology, University, Intraoperative electron radiation therapy, CHUM, Cancer, Research, University of Wisconsin Carbone Cancer Center, Sale, CHUV, University of Lausanne, MD Anderson Cancer Center, Radiation therapy, Radiation, FLASH, Patient, NMSC, Ultra, Growth, Ides, Lausanne University Hospital, Pharmaceutical industry, Nightclub

IntraOp Medical Corporation proudly announces that its IntraOp® Mobetron® with FLASH-IQ™ technology will soon be installed in its tenth institution worldwide, marking a significant milestone in the study of FLASH radiotherapy.

Key Points: 
  • IntraOp Medical Corporation proudly announces that its IntraOp® Mobetron® with FLASH-IQ™ technology will soon be installed in its tenth institution worldwide, marking a significant milestone in the study of FLASH radiotherapy.
  • IntraOp Mobetron with FLASH-IQ is a novel radiotherapy platform capable of delivering an Ultra-High Dose Rate (UHDR) electron beam.
  • Several additional sites are applying for IDEs in the US, along with Canada, Belgium and Germany applying for similar exemptions in their countries.
  • IntraOp supports these applications and looks forward to the continued growth and development in the study of FLASH radiotherapy.

dscout Makes Strategic Moves to Solidify its Leadership Position in Human Experience Research

Retrieved on: 
Thursday, March 16, 2023
Acquisition, Marketing research, United Kingdom, Market Research Society, Software as a service, University of Wisconsin Carbone Cancer Center, Nielsen, Human, Organization, Investment, Growth, Content, Heel, Talkington, University, Marketing, KPMG, Management, Research

CHICAGO, March 16, 2023 /PRNewswire-PRWeb/ -- dscout, the end-to-end human experience research platform, today announced a number of strategic moves and investments that solidify the company's position and demonstrate its leadership in the experience research category.

Key Points: 
  • CHICAGO, March 16, 2023 /PRNewswire-PRWeb/ -- dscout , the end-to-end human experience research platform, today announced a number of strategic moves and investments that solidify the company's position and demonstrate its leadership in the experience research category.
  • To provide a seamless experience for organizations running research with their own participants, dscout has acquired Panelfox , an all-in-one software platform that helps researchers build panels and manage recruitment for research.
  • dscout places a high value on user experience and beautiful design, and has the potential to radically change the way businesses conduct human experience research.
  • "dscout is already the preferred platform of choice for human experience research, and has massive potential to drive the industry forward," said Chip Hardt , Chief Operating Officer, dscout.

Surgery First for Colon Cancer? Not So Fast, According to New Study in JNCCN

Retrieved on: 
Wednesday, January 11, 2023
University, CRC, Colorectal cancer, Immunotherapy, National Comprehensive Cancer Network, Sun Yat-sen University Cancer Center, Safety, Surgeon, State Key Laboratories, University of Wisconsin Carbone Cancer Center, Sun, Financial toxicity, Neoplasm, NCCN, Nominal interest rate, Patient, Research, Cancer, PD-1, Recurrence, Pharmaceutical industry, MD

PLYMOUTH MEETING, Pa., Jan. 11, 2023 /PRNewswire/ -- New research in the January 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that immunotherapy from immune checkpoint (PD-1) inhibitors prior to surgery was strikingly effective for patients with localized mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC). Nearly all of the patients studied benefitted from neoadjuvant PD-1 inhibitors, with 1-of-4 experiencing complete response on clinical assessment. In addition to the short-term effectiveness, the findings showed substantial longer survival benefits from neodjuvant PD-1 inhibitors, including a low recurrence rate when compared with historic rates.

Key Points: 
  • Nearly all of the patients studied benefitted from neoadjuvant PD-1 inhibitors, with 1-of-4 experiencing complete response on clinical assessment.
  • Of those 73, 48 were diagnosed with colon cancer, 18 with rectal cancer, and 7 with multiple types of CRC.
  • The 2-year rates for tumor-specific overall survival and disease-free survival were 100% for patients who underwent surgery after PD-1 blockade.
  • The study had an average follow-up time of 17.2 months, with 16 patients tracked for more than two years.

Strata Oncology and University of Wisconsin Carbone Cancer Center Integrate StrataNGS® Test Results with Epic Genomics Module to Enhance Research and Workflows

Retrieved on: 
Wednesday, September 7, 2022
University of Wisconsin Carbone Cancer Center, University, RNA, Cancer, Research, ANN, Oncology, UW Health University Hospital, Precision medicine, MSI, EMR, Physician, Health, Microsatellite instability, TMB, Medicare, Therapy, Genomics, Patient, Medical imaging

ANN ARBOR, Mich., Sept. 7, 2022 /PRNewswire/ -- Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced the integration of discrete genomic data from its StrataNGS® next-generation sequencing-based tumor profiling with the University of Wisconsin Carbone Cancer Center and UW Health Epic genomics module.

Key Points: 
  • "For many oncologists, genomic reports are inaccessible in hard-to-find scanned documents," said Mark Burkard, M.D., Ph.D., associate director of genomics and precision medicine at the University of Wisconsin Carbone Cancer Center.
  • This collaboration will ensure that UW Health and University of Wisconsin Carbone Cancer Center delivers remarkable care."
  • "By integrating data from StrataNGS into the Epic genomics module, the University of Wisconsin Carbone Cancer Center will be able to more efficiently and effectively use genomic data to treat and understand cancer," said Dan Rhodes, Ph.D., co-founder and Chief Executive Officer, Strata Oncology.
  • Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer.

Organic Dairy Farming Can Store Carbon and Reduce Greenhouse Gas Emissions, According to New Study in Journal of Cleaner Production

Retrieved on: 
Friday, August 19, 2022
University of Wisconsin–Madison, University, Food, Program, Research, Soil, Carbon, YouTube, Frontier Natural Products Co-op, Temperature, Manure, LinkedIn, Science, Farmer, Journal, Journal of Cleaner Production, LCA, Animal, LA, University of Wisconsin Carbone Cancer Center, Organic farming, Cattle, Twitter, Farm, United Kingdom, Health, Longevity, Extension, GHG, Nature, Agriculture, Livestock, Organic Valley, Instagram, Facebook

LA FARGE, Wis., Aug. 19, 2022 /PRNewswire/ -- A new study in the August issue of the Journal of Cleaner Production reveals that it is possible for farms to sequester carbon and reduce their overall greenhouse gas emissions. A University of Wisconsin Madison research group unveiled a dairy lifecycle assessment conducted on Organic Valley farms that shows small organic dairy farms, which focus on grazing and organic production techniques, are low greenhouse gas champions. 

Key Points: 
  • LA FARGE, Wis., Aug. 19, 2022 /PRNewswire/ -- A new study in the August issue of the Journal of Cleaner Production reveals that it is possible for farms to sequester carbon and reduce their overall greenhouse gas emissions.
  • A University of Wisconsin Madison research group unveiled a dairy lifecycle assessment conducted on Organic Valley farms that shows small organic dairy farms, which focus on grazing and organic production techniques, are low greenhouse gas champions.
  • "The study proposes a method to include carbon sequestration not only in organic but all dairy farm-related LCA studies.
  • SOURCE: Regional analysis of greenhouse gas emissions from USA dairy farms: A cradle to farm-gate assessment of the American dairy industry circa 2008, International Dairy Journal

Organic Dairy Farming Can Store Carbon and Reduce Greenhouse Gas Emissions, According to New Study in Journal of Cleaner Production

Retrieved on: 
Thursday, August 18, 2022
University of Wisconsin–Madison, Farmer, United Kingdom, Carbon, LCA, YouTube, Soil, Journal of Cleaner Production, Research, Cattle, Temperature, Food, Twitter, Extension, Program, University of Wisconsin Carbone Cancer Center, LA, Frontier Natural Products Co-op, Nature, Longevity, GHG, Manure, Farm, Science, Journal, University, Organic farming, LinkedIn, Animal, Health, Agriculture, Livestock, Facebook, Instagram, Organic Valley

LA FARGE, Wis., Aug. 18, 2022 /PRNewswire/ -- A new study in the August issue of the Journal of Cleaner Production reveals that it is possible for farms to sequester carbon and reduce their overall greenhouse gas emissions. A University of Wisconsin Madison research group unveiled a dairy lifecycle assessment conducted on Organic Valley farms that shows small organic dairy farms, which focus on grazing and organic production techniques, are low greenhouse gas champions.

Key Points: 
  • A University of Wisconsin Madison research group unveiled a dairy lifecycle assessment conducted on Organic Valley farms that shows small organic dairy farms, which focus on grazing and organic production techniques, are low greenhouse gas champions.
  • New U.S. study reveals the positive carbon sequestration results of cows spending time on organic pastures.
  • "The study proposes a method to include carbon sequestration not only in organic but all dairy farm-related LCA studies.
  • SOURCE: Regional analysis of greenhouse gas emissions from USA dairy farms: A cradle to farm-gate assessment of the American dairy industry circa 2008, International Dairy Journal

Wisconsin US Navy Veterans Mesothelioma Advocate Recommends the Law Firm of Danziger & De Llano for a Navy Veteran with Just Diagnosed Mesothelioma in Wisconsin-Get a Better Compensation Result That Might be Millions

Retrieved on: 
Tuesday, June 28, 2022
Mesothelioma, Llano, Oshkosh, National Institutes of Health campus, Cancer, United States Navy Veterans Association, National, Navy, University, University of Wisconsin Carbone Cancer Center, Incidence, Advocate, Family, Asbestos, Real estate, Oil, United States Navy

Mesothelioma compensation for a Navy Veteran with this rare cancer frequently exceeds $1,000,000.

Key Points: 
  • Mesothelioma compensation for a Navy Veteran with this rare cancer frequently exceeds $1,000,000.
  • Before a Navy Veteran who has been diagnosed with mesothelioma hires a lawyer to assist with compensation, please call the remarkable team at the law firm ofDanziger&De Llano at 800-864-4000.
  • https://meso.dandell.com
    The US Navy Veterans Mesothelioma Advocate's services are available to US Navy Veterans with mesothelioma in Milwaukee, Madison, Green Bay, Kenosha, Racine, Appleton, Oshkosh or anywhere in Wisconsin.
  • For the best treatment option in Wisconsin the Wisconsin US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facility.

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN

Retrieved on: 
Monday, February 7, 2022
Policy, Pain, Pre-exposure prophylaxis, CDC, Cancer, Decision-making, Caregiver, FABS, Hospital, RNA transfection, Health, Myalgia, Fever, Fox Chase Cancer Center, Chills, Temple University, Department, Research, NCCN, Headache, National Comprehensive Cancer Network, Vaccination, Report, Public policy, Strathcona County, Education, Infection, MD, Radiation therapy, Harborside, Twitter, Incidence, Bioethics, Risk, Oncology, Patient, Review, Effectiveness, COVID-19, Journal of the National Comprehensive Cancer Network, Nausea, Pfizer, University of Wisconsin Carbone Cancer Center, Arthralgia, University, Immunotherapy, Death, Physician, Vaccine, Fatigue, Pharmaceutical industry, Medicine

PLYMOUTH MEETING, Pa., Feb. 7, 2022 /PRNewswire/ -- New research in the February 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms that mRNA vaccine for COVID-19 are just as safe for people with cancer as they are for cancer-free individuals. Researchers from Fox Chase Cancer Center tracked short-term side-effects from more than 1,753 recipients of the Pfizer BNT162b2 vaccine, and found no additional reactions for patients undergoing active cancer treatment (surgery, chemotherapy, immunotherapy, or radiation therapy) or who had completed treatment.

Key Points: 
  • "We now have the data and the clinical experience from thousands and thousands and thousands of cancer patients who have been vaccinated.
  • We know that the mRNA vaccines are safe and are absolutely the most effective way to prevent hospitalization and death from COVID-19."
  • This study demonstrates that cancer patients experience no greater rate of complications and should help to counteract misinformation about COVID-19 vaccinations.
  • More than 25,000 oncologists and other cancer care professionals across the United States readJNCCNJournal of the National Comprehensive Cancer Network.